HM12470

BIOLOGICAL3 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Diabetes MellitusHealthy SubjectsType1 Diabetes MellitusType2 Diabetes Mellitus

Phase 1

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470

CompletedNCT02302443

Hanmi Pharmaceutical Company LimitedDiabetes Mellitus

Start: 2015-01-31End: 2017-05-31Updated: 2017-11-08

Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Hanmi Pharmaceutical Company LimitedType1 Diabetes Mellitus, Type2 Diabetes Mellitus

Start: 2015-07-28End: 2018-04-30Updated: 2017-11-06

Molar Potency Study of HM12470 in Healthy Subjects

CompletedNCT03330327

Hanmi Pharmaceutical Company LimitedHealthy Subjects

Start: 2015-03-30End: 2017-08-17Updated: 2017-11-06